These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36187114)
1. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF Hamada K; Kurashige T; Shimamura M; Arakawa H; Nakamura Y; Nagayama Y Front Endocrinol (Lausanne); 2022; 13():932754. PubMed ID: 36187114 [TBL] [Abstract][Full Text] [Related]
2. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504 [TBL] [Abstract][Full Text] [Related]
3. Acceleration of BRAF Shimamura M; Kurashige T; Kuatov R; Nakashima M; Nagayama Y Endocrine; 2020 Sep; 69(3):571-577. PubMed ID: 32281047 [TBL] [Abstract][Full Text] [Related]
4. Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53. Nakamura Y; Arakawa H Cancer Sci; 2017 May; 108(5):809-817. PubMed ID: 28222492 [TBL] [Abstract][Full Text] [Related]
5. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260 [TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone (T Yau WW; Singh BK; Lesmana R; Zhou J; Sinha RA; Wong KA; Wu Y; Bay BH; Sugii S; Sun L; Yen PM Autophagy; 2019 Jan; 15(1):131-150. PubMed ID: 30209975 [TBL] [Abstract][Full Text] [Related]
8. Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Strohecker AM; White E Autophagy; 2014 Feb; 10(2):384-5. PubMed ID: 24362353 [TBL] [Abstract][Full Text] [Related]
9. Kim M; Kim SJ; Xu Z; Ha SY; Byeon JH; Kang EJ; Shin SH; Yoo SK; Jee HG; Yoon SG; Yi JW; Bae JM; Yu HW; Chai YJ; Cho SW; Choi JY; Lee KE; Han W Thyroid; 2020 Apr; 30(4):487-500. PubMed ID: 32122255 [No Abstract] [Full Text] [Related]
10. Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma. Shimamura M; Nakahara M; Orim F; Kurashige T; Mitsutake N; Nakashima M; Kondo S; Yamada M; Taguchi R; Kimura S; Nagayama Y Endocrinology; 2013 Nov; 154(11):4423-30. PubMed ID: 23970782 [TBL] [Abstract][Full Text] [Related]
11. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy. Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963 [TBL] [Abstract][Full Text] [Related]
12. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation. Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E. Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530 [TBL] [Abstract][Full Text] [Related]
15. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers. Sano H; Futamura M; Gaowa S; Kamino H; Nakamura Y; Yamaguchi K; Tanaka Y; Yasufuku I; Nakakami A; Arakawa H; Yoshida K Biochem Biophys Res Commun; 2020 Aug; 529(3):582-589. PubMed ID: 32736677 [TBL] [Abstract][Full Text] [Related]
16. Jiménez-Mora E; Gallego B; Díaz-Gago S; Lasa M; Baquero P; Chiloeches A Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204950 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial metabolism is inhibited by the HIF1α-MYC-PGC-1β axis in BRAF V600E thyroid cancer. Gao Y; Yang F; Yang XA; Zhang L; Yu H; Cheng X; Xu S; Pan J; Wang K; Li P FEBS J; 2019 Apr; 286(7):1420-1436. PubMed ID: 30768848 [TBL] [Abstract][Full Text] [Related]
18. β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAF Zou M; BinEssa HA; Al-Malki YH; Al-Yahya S; Al-Alwan M; Al-Jammaz I; Khabar KSA; Almohanna F; Assiri AM; Meyer BF; Alzahrani AS; Al-Mohanna FA; Shi Y Mol Cancer Ther; 2021 Sep; 20(9):1603-1613. PubMed ID: 34224366 [No Abstract] [Full Text] [Related]
19. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma. Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601 [TBL] [Abstract][Full Text] [Related]
20. Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAF(V600E)-induced thyroid tumors in a mouse model. Orim F; Bychkov A; Shimamura M; Nakashima M; Ito M; Matsuse M; Kurashige T; Suzuki K; Saenko V; Nagayama Y; Yamashita S; Mitsutake N Thyroid; 2014 Mar; 24(3):502-10. PubMed ID: 23924149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]